European Archives - Page 1089 of 1104 - European Medical Journal

EMJ

Enzyme Revealed as Promising Target to Treat Asthma and Cancer

In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells…

EMJ

Review of Testosterone-Containing Medicines Started

The European Medicines Agency has started a review of testosterone-containing medicines, mainly used in men who do not produce enough testosterone…

EMJ

International Coeliac Day 16 May 2014

As part of this year’s International Coeliac Day, AOECS is raising awareness for an improvement in diagnosis rates of coeliac disease.

EMJ

Caffeine against Alzheimer’s Disease

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the…

EMJ

Adverse Events

A year after I graduated, I was working in an emergency department when one of my colleagues killed someone.

EMJ

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

EMJ

Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between…

EMJ

Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to…

EMJ

‘Early Access’ Scheme Unveiled for Innovative Medicines

People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments.

EMJ

NICE Consults on Draft Guidance Recommending New Drug for Type 2 Diabetes

NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in combination with…